Fig. 1From: Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunitiesDirect targeting of KRAS. ASOs: Antisense Oligonucleotides; GAP: GTP-ase Activating Proteins; GEF: Guanine Nucleotide Exchange Factor; G4: G-quadruplex; RTKs: Receptor Tyrosine KinasesBack to article page